Trade Alert: The Head of Technical Operations Of Swedish Orphan Biovitrum AB (publ) (STO:SOBI), Anne de Jonge Schuermans, Has Just Spent kr1.3m Buying A Few More Shares

Simply Wall St
November 23, 2021
Source: Shutterstock

Investors who take an interest in Swedish Orphan Biovitrum AB (publ) (STO:SOBI) should definitely note that the Head of Technical Operations, Anne de Jonge Schuermans, recently paid kr230 per share to buy kr1.3m worth of the stock. Although the purchase is not a big one, by either a percentage standpoint or absolute value, it can be seen as a good sign.

View our latest analysis for Swedish Orphan Biovitrum

Swedish Orphan Biovitrum Insider Transactions Over The Last Year

In the last twelve months, the biggest single purchase by an insider was when CEO & President Guido Oelkers bought kr8.2m worth of shares at a price of kr149 per share. We do like to see buying, but this purchase was made at well below the current price of kr221. While it does suggest insiders consider the stock undervalued at lower prices, this transaction doesn't tell us much about what they think of current prices.

Swedish Orphan Biovitrum insiders may have bought shares in the last year, but they didn't sell any. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. By clicking on the graph below, you can see the precise details of each insider transaction!

OM:SOBI Insider Trading Volume November 24th 2021

There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of growing companies that insiders are buying.

Insider Ownership

Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. We usually like to see fairly high levels of insider ownership. Swedish Orphan Biovitrum insiders own about kr100m worth of shares. That equates to 0.2% of the company. We've certainly seen higher levels of insider ownership elsewhere, but these holdings are enough to suggest alignment between insiders and the other shareholders.

So What Does This Data Suggest About Swedish Orphan Biovitrum Insiders?

It is good to see recent purchasing. We also take confidence from the longer term picture of insider transactions. Along with the high insider ownership, this analysis suggests that insiders are quite bullish about Swedish Orphan Biovitrum. Looks promising! In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Swedish Orphan Biovitrum. At Simply Wall St, we found 1 warning sign for Swedish Orphan Biovitrum that deserve your attention before buying any shares.

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at)

Discounted cash flow calculation for every stock

Simply Wall St does a detailed discounted cash flow calculation every 6 hours for every stock on the market, so if you want to find the intrinsic value of any company just search here. It’s FREE.

Simply Wall St character - Warren

Simply Wall St

Simply Wall St is focused on providing unbiased, high-quality research coverage on every listed company in the world. Our research team consists of data scientists and multiple equity analysts with over two decades worth of financial markets experience between them.